Farmacat: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Farmacat
Largest movements
- Cash +€92,101
up €92,101 (+214%), from €43,063 to €135,165
mainly Other debts (+€175,436) and Net result for the year (+€141,799)
- Other debts +€175,436
up €175,436 (+10.2%), from €1.7m to €1.9m
- Reserves +€141,799
up €141,799 (+10.2%), from €1.4m to €1.5m
- Current portion of long-term debt -€138,578
down €138,578 (-73.2%), from €189,296 to €50,718
- Debts after one year -€50,718
down €50,718 (-47.8%), from €106,094 to €55,376
- Accrued charges and deferred income -€49,453
down €49,453 (-54.9%), from €90,128 to €40,675
- Gross operating margin -€133,870
down €133,870 (-31.4%), from €426,769 to €292,898
- Financial charges -€60,529
down €60,529 (-41.4%), from €146,313 to €85,784
- Taxes -€24,119
down €24,119 (-28.3%), from €85,287 to €61,168
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,585,606 | €3,666,109 | +€80,503 | +2.2% |
| Fixed assets | 21/28 | €3,367,341 | €3,388,952 | +€21,610 | +0.6% |
| Tangible fixed assets | 22/27 | €18,055 | €39,665 | +€21,610 | +120% |
| Furniture and vehicles | 24 | €18,055 | €39,665 | +€21,610 | +120% |
| Financial fixed assets | 28 | €3,349,287 | €3,349,287 | = | 0.0% |
| Current assets | 29/58 | €218,265 | €277,157 | +€58,892 | +27.0% |
| Amounts receivable within one year | 40/41 | €171,786 | €141,222 | -€30,564 | -17.8% |
| Trade receivables | 40 | €80,098 | €36,300 | -€43,798 | -54.7% |
| Other amounts receivable | 41 | €91,688 | €104,922 | +€13,234 | +14.4% |
| Cash at bank and in hand | 54/58 | €43,063 | €135,165 | +€92,101 | +214% |
| Deferred charges and accrued income | 490/1 | €3,415 | €770 | -€2,645 | -77.5% |
| Total equity and liabilities | 10/49 | €3,585,606 | €3,666,109 | +€80,503 | +2.2% |
| Equity | 10/15 | €1,396,117 | €1,537,916 | +€141,799 | +10.2% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,383,717 | €1,525,516 | +€141,799 | +10.2% |
| Distributable reserves | 133 | €1,383,717 | €1,525,516 | +€141,799 | +10.2% |
| Amounts payable | 17/49 | €2,189,490 | €2,128,193 | -€61,296 | -2.8% |
| Amounts payable after more than one year | 17 | €106,094 | €55,376 | -€50,718 | -47.8% |
| Financial debts | 170/4 | €106,094 | €55,376 | -€50,718 | -47.8% |
| Amounts payable within one year | 42/48 | €1,993,268 | €2,032,142 | +€38,875 | +2.0% |
| Current portion of amounts payable after more than one year | 42 | €189,296 | €50,718 | -€138,578 | -73.2% |
| Trade debts | 44 | €32,361 | €59,024 | +€26,662 | +82.4% |
| Suppliers | 440/4 | €32,361 | €59,024 | +€26,662 | +82.4% |
| Taxes, remuneration and social security | 45 | €54,576 | €29,929 | -€24,646 | -45.2% |
| Taxes | 450/3 | €48,506 | €26,893 | -€21,613 | -44.6% |
| Remuneration and social security | 454/9 | €6,069 | €3,036 | -€3,033 | -50.0% |
| Other amounts payable | 47/48 | €1,717,035 | €1,892,471 | +€175,436 | +10.2% |
| Accrued charges and deferred income | 492/3 | €90,128 | €40,675 | -€49,453 | -54.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,669 | €7,126 | +€1,456 | +25.7% |
| Other operating charges | 640/8 | €1,629 | €1,568 | -€60 | -3.7% |
| Gross operating margin | 9900 | €426,769 | €292,898 | -€133,870 | -31.4% |
| Operating profit (loss) | 9901 | €419,471 | €284,205 | -€135,266 | -32.2% |
| Financial income | 75/76B | €4,579 | €4,546 | -€32 | -0.7% |
| Recurring financial income | 75 | €4,579 | €4,546 | -€32 | -0.7% |
| Financial charges | 65/66B | €146,313 | €85,784 | -€60,529 | -41.4% |
| Recurring financial charges | 65 | €146,313 | €85,784 | -€60,529 | -41.4% |
| Profit (loss) for the period before taxes | 9903 | €277,736 | €202,967 | -€74,769 | -26.9% |
| Income taxes | 67/77 | €85,287 | €61,168 | -€24,119 | -28.3% |
| Profit (loss) for the period | 9904 | €192,449 | €141,799 | -€50,650 | -26.3% |
| Profit (loss) for the period to be appropriated | 9905 | €192,449 | €141,799 | -€50,650 | -26.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.